Tara Mann
Adult Health · Riverhead, NYNPI 1639510837
Payments from drug & device makers
Across 112 payments — averaging $20.13 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$396
- Merck$296
- Pfizer$288
- Johnson & Johnson$188
- E.r. Squibb & Sons, L.L.C.$162
- Sanofi-aventis U.S. LLC$159
- plus $765 from 15 others
What the payments were for
- Food & beverage$2,254100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 20 | $396 |
| Merck | 15 | $296 |
| Pfizer | 17 | $288 |
| Johnson & Johnson | 9 | $188 |
| E.r. Squibb & Sons, L.L.C. | 10 | $162 |
| Sanofi-aventis U.S. LLC | 6 | $159 |
| Boehringer Ingelheim | 6 | $145 |
| Amgen | 5 | $99 |
| Actelion Pharmaceuticals US, Inc. | 3 | $71 |
| Novo Nordisk | 3 | $60 |
| Edwards Lifesciences | 3 | $58 |
| Amarin Pharma, Inc. | 2 | $46 |
| Daiichi Sankyo Inc. | 2 | $45 |
| Medtronic | 1 | $40 |
| Boston Scientific | 2 | $39 |
| Scpharmaceuticals Inc. | 2 | $38 |
| Abbott | 2 | $35 |
| Alnylam Pharmaceuticals Inc. | 1 | $29 |
| Baxter Healthcare | 1 | $27 |
| AstraZeneca | 1 | $17 |
| Esperion Therapeutics, Inc. | 1 | $17 |
How this compares
$2,254 in reported general payments places this provider in the 80th percentile of 3,828 adult health providers in New York.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 216 | $278,463 |
| XareltoRivaroxaban | 100 | $122,038 |
| EntrestoSacubitril/Valsartan | 70 | $96,429 |
| BrilintaTicagrelor | 17 | $19,069 |
| JardianceEmpagliflozin | 13 | $15,431 |
| Praluent PenAlirocumab | 16 | $13,462 |
| Metoprolol Succinate | 405 | $7,189 |
| Repatha SureclickEvolocumab | 11 | $6,860 |
| Nebivolol Hcl | 64 | $3,800 |
| Atorvastatin Calcium | 175 | $2,015 |
| Diltiazem 24hr Er (Cd)Diltiazem Hcl | 66 | $1,920 |
| Amiodarone Hcl | 46 | $1,654 |
| Amlodipine Besylate | 259 | $1,643 |
| Losartan Potassium | 189 | $1,636 |
| ClopidogrelClopidogrel Bisulfate | 161 | $1,508 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $288 | $278,463216 claims |
| Johnson & JohnsonXarelto | $188 | $122,038100 claims |
| NovartisEntresto | $396 | $96,42970 claims |
| AstraZenecaBrilinta | $17 | $19,06917 claims |
| Boehringer IngelheimJardiance | $145 | $15,43113 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,828 adult health providers in New York.
Other adult health in Riverhead
- Frank AlbanoRiverhead$37K
- Marguerite CallahanNew York$1.4M
- Donna CatameroNew York$279K
- Kristen DurkinPort Jefferson Station$255K
- Katelyn McCormackAmherst$201K
- Mary CiechoskiBuffalo$200K
- Patricia LorussoLancaster$161K
- Jennifer FioriniGlens Falls$151K
- Tia AlbroRochester$142K
- Maria Gigante-BaggettEast Syracuse$92K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.